Eli Lilly stock gains on weight loss drug that cuts Type 2 diabetes risk by 94%
ฝัง
- เผยแพร่เมื่อ 11 ก.ย. 2024
- Shares of Eli Lilly are moving higher on Tuesday after the company revealed that a recent study, conducted by the company, showed that its weight-loss drug tirzepatide, the active ingredient in its weight-loss drug Zepbound and diabetes drug Mounjaro, cuts diabetes risk by 94%.
Mizuho healthcare equity strategist Jared Holz joins Market Domination to give insight into the data from Eli Lilly and just how much opportunity this drug has for the market and in healthcare.
"I mean, a 94% decline in Type two almost makes me feel like everyone should be on the drug, irrespective of whether they're obese or not. So I think this just continues to open up the market for other indications for the company," says Holz.
He follows that up with: "I think as we move forward here into 2025, I think every single analyst on the Street is going to start to talk up, slash hype, the opportunity in Alzheimer's disease as being another inflammatory indication that's clearly massive, that these drugs could potentially work for. And I think we're going to have data -- I think Novo (NVO) is going to have their data on Alzheimer's disease in the second half of next year, so about a year from now. So I don't think we've ever seen anything like it."About Yahoo Finance:
Yahoo Finance provides free stock ticker data, up-to-date news, portfolio management resources, comprehensive market data, advanced tools, and more information to help you manage your financial life.
- Get the latest news and data at finance.yahoo.com
- Download the Yahoo Finance app on Apple (apple.co/3Rten0R) or Android (bit.ly/3t8UnXO)
- Follow Yahoo Finance on social:
X: / yahoofinance
Instagram: www.instagram....
TikTok: www.tiktok.com...
Facebook: / yahoofinance
LinkedIn: / yahoo-finance
AWS91K is still extremely undervalued
AWS to the moon! 🚀
Just read news about AWS this morning. Presale is open right now
Totally agree! Let's go AWS! 🌟
I'm All-In
really good project
Thanks for sharing TON and AWS91K. 💯
AWS is promising! Happy to be part of this journey.
AWS is a great investment choice!
AWS's journey will be exciting!
Excited about AWS too! It’s great seeing our investments grow together. Let's keep it up! 🚀
Happy to invest in AWS together!
Every medicine comes with side effects. Taking any medication especially hormones has to be balanced with what are the consequences of not treating a condition and a patients tolerance to a medication, which is why Tirzepatide and Semaglutide is prescribed at low doses initially and in this case diabetes and obesity which each are life changing conditions both physically and mentally but having both these conditions together is catastrophic for a patient. So Mounjaro is a god send for patients suffering with any of these conditions. Leaving obesity and or diabetes unchecked will make you wise you was never born, I’ve seen the effects of leaving these conditions untreated and finally a genuine miracle has been created to actually end these illnesses once and for all!
J'ai montré cette vidéo à mes enfants et maintenant ils rient si fort que les voisins sont venus voir ce qui s'est passé💖
No long term studies? side effects?
Classic manipulation in comments from one month old accounts.
Bought AWS91K after watching your video, super excited! 💰
undervalued project
this is a life changing project
thanks for sharing, I just bought it
all of my friends told me to buy this, I did know it was from Amazon
lets PUMP this to the sky guys!!
If we can rethink the relationship between Economics and Money I think we'll be able to transcend dimensions
Thanks for the advice! Got AWS91K, feeling bullish! 🚀
Classic manipulation in comments.
New account.
Loving SOL and AWS91K! Following your advice has made me $30K in profits. Super excited for the future of these projects!
Classic manipulation in comments.
New account.